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The cell envelope of Mycobacterium tuberculosis (Mtb) is complex and diverse; composed of proteins
intermingled in a matrix of peptidoglycan, mycolic acids, lipids, and carbohydrates. Proteomic studies
of the Mtb cell wall have been limited; nonetheless, the characterization of resident and secreted proteins
associated with the cell wall are critical to understanding bacterial survival and immune modulation in
the host. In this study, the cell wall proteome was deﬁned in order to better understand its unique
biosynthetic and secretion processes. Mtb cell wall was subjected to extraction with organic solvents
to remove noncovalently bound lipids and lipoglycans and remaining proteins were solubilized with
either SDS, Guanidine-HCl, or TX-114. These extracts were analyzed by two-dimensional gel electro-
phoresis and mass-spectrometry and resulted in the identiﬁcation of 234 total proteins. The lipoproteome
of Mtb, enriched in the TX-114 extract, was further resolved by multidimensional chromatography and
mass spectrometry to identify an additional 294 proteins. A query of the 528 total protein identiﬁcations
against Neural Network or Hidden Markov model algorithms predicted secretion signals in 87 proteins.
Classiﬁcation of these 528 proteins also demonstrated that 35% are involved in small molecule
metabolism and 25% are involved in macromolecule synthesis and degradation building upon evidence
that the Mtb cell wall is actively engaged in mycobacterial survival and remodeling.
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Introduction
Despite efforts to eradicate tuberculosis, it remains one of
the most successful and deadly human diseases. The tubercle
bacilli resides within dendritic cells and macrophages, and in
an immunocompetent host, the infection is walled off within
a granuloma where it can remain dormant for years. While
many factors contribute to its success, it is the thick, waxy cell
wall of the bacillus that prevents dehydration, affords protec-
tion against varying levels of acidity and the detrimental affects
of free radicals. In many respects, it is the unique architecture
of the cell wall itself that makes Mycobacterium tuberculosis
(Mtb) infection relatively difﬁcult to treat with antibiotics. Since
it is also a reservoir for many proteins and nonproteinaceous
antigens, which are secreted into the extracellular milieu to
stimulate and/or suppress the host immune response,
1,2 its
deﬁnition can be exploited for vaccine development.
For decades, the macromolecular features of the mycobac-
terial cell wall, including the mycolic acid and arabinogalactan
core, have been studied in detail.
3 Structurally, the cell wall of
Mtb is composed of a distinct inner core of mycolic acid-
arabinogalactan-peptidoglycan (mAGP). In addition to the
covalently attached lipids and carbohydrates, it is well-known
that the free lipids, lipoglycans, and phosphotidyl inositols that
reside in the outer core of the cell wall play key roles in
modulation of the host immune response.
4 Speciﬁcally, the
molecules, lipoarabinomannan (LAM), lipomannan (LM), and
phosphatidyl inositol mannoside (PIM) are known to aid the
process of host immune evasion.
2 In addition, virulence lipids
such as trehalose dimycolate/monomycolate (TDM/TMM),
phthiocerol dimycocerosate (PDIM), and sulfolipids (SL) and
the protein machinery, such as MmpLs, required for their
export are intercalated in the cell wall.
5
Numerous cell wall associated proteins, including many
lipoproteins and lipoglycoproteins, have also been described.
6-8
For example, the TLR2 agonists, lpqH (19 kDa), pstS1 (38 kDa),
and lprG (Rv14llc), are all found in the cell wall,
7-11 where they
function to regulate the action of macrophages and dendritic
cells.
12 PstS1 also plays a role in bacterial escape from the host
macrophage through apoptosis.
13 Many other lipoproteins of
unknown function are identiﬁed in the secreted proteome of
Mtb culture ﬁltrate.
14-16
The study of the secreted proteome of Mtb was driven by
the search for novel immunodominant antigens, drug targets,
and biomarkers for disease.
17-20 To build upon this work, a
number of studies employed advances in proteomic technolo-
gies such as two-dimensional gel electrophoresis (2DGE) and
liquid chromatography mass spectrometry (LC-MS/MS)
to further mine additional subcellular compartments of
Mtbscytosol, membrane, and cell wall.
21-26 Historically, the
proteins within the cell wall have been difﬁcult to resolve and
identify by traditional 2DGE methods.
19,27 Mawuenyega et al.,
employing two-dimensional liquid chromatography coupled
with mass spectrometry (2DLC/MS) were the most successful
at deﬁning the cell wall proteome with the identiﬁcation of 306 * Corresponding author. E-mail: kdobos@colostate.edu.
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24 In this study, we set out to comprehensively describe
the Mtb cell wall proteome in an effort to exploit additional
proteins that may play a role in host-pathogen interactions and
deﬁne new potential drug targets via discovery of unique
biosynthetic or metabolic processes. We used a combination
of detergent extraction, 2DGE, multidimensional liquid chro-
matography, and mass spectrometry to achieve our goal.
Methods
Preparation of Mtb Cell Wall. Mtb strain H37Rv was cultured
i n2Lo fglycerol alanine salts (GAS) medium
28 in roller bottles
f o r1 4da t3 7°C with gentle agitation. Cells were harvested,
24
washed with phosphate-buffered saline (PBS), pH 7.4, and
inactivated by γ-irradiation. Cells were disrupted in a French
press, free lipids were removed, and the cell wall was obtained
as previously described.
29 Brieﬂy,1go flyophilized cell wall
was subjected to two extractions of 2 h each followed by one
18 h extraction with chloroform/methanol (2:1, v/v) at a ratio
of 30 mL/g of cell wall. Extractions were performed at 22 °C
with agitation. Centrifugation at 27 000g for 30 min was
performed to collect cell wall material. The 2:1 extracted cell
wall was dried under N2 and further extracted twice for 2 h
and one 18 h extraction with chloroform/methanol/water (10:
10:3, v/v/v) each at 22 °C. The fully delipidated cell wall was
dried under N2 and resuspended in PBS, pH 7.4. Cell wall
protein was quantiﬁed by bicinchoninic acid (BCA) assay
(Thermo Pierce).
Detergent Extractions of Cell Wall Proteins. Cell wall
protein (CWP) was solubilized by one of three methods using
(i) 6 M guanidine HCl (GuHCl), (ii) 2% sodium dodecyl sulfate
(SDS), or (iii) 4% TritionX-114 (TX-114). For method (i), 75 mg
of CWP was incubated at 22 °C for 4 h with agitation. The
sample was centrifuged at 27 000g for 30 min. Solubilized
proteins were exchanged into 0.01 M NH4HCO3, and the protein
amount was determined by BCA assay. The average protein
recovery following GuHCl extraction of CWP was 40%. For
method (ii), SDS soluble proteins were generated by extraction
of 100 mg of CWP with 2% SDS in PBS (w/v) as described
previously.
29 Brieﬂy, the sample was bath sonicated for3ha t
90 °C. The sample was centrifuged at 27 000g at 22 °C for 30
min, collected, and centrifuged again. The fully cleared super-
natant was then subjected to paired-ion extraction for removal
of SDS.
30 Proteins were concentrated by centrifugation as above
and pellets washed with acetone at -20 °C for 4 h. The ﬁnal
pellet was resuspended in 0.01 M NH4HCO3 and protein
amount was determined by BCA. The average protein recovery
following SDS extraction of CWP was 60%. In method (iii), a
stock solution of 32% TX-114 in PBS was added to 300 mg of
CWP to a ﬁnal concentration of 4% detergent. Primary extrac-
tion occurred at 4 °C for 16 h. The extract was allowed to
biphase at 37 °C for 30 min and was fully separated by
centrifugation at 27 000g for 30 min. Each phase was back
extracted two additional times for 2 h each. The TX-114
detergent phases were pooled, and proteins collected by cold
acetone precipitation.
31 Final TX-114 proteins were resus-
pended as above and protein amount was determined by BCA
assay. Protein recovery following TX-114 extraction of CWP was
5%.
Two-Dimensional Gel Electrophoresis (2DGE). Samples of
200 µg of each CWP preparation were solubilized for 9-14 h
in rehydration buffer (7 M urea/2 M thiourea, 1% amidosul-
fobetaine-14 (ASB-14), 1% 3-[(3-cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate (CHAPS), 1 mM dithiothreitol
(DTT), 0.25% NP-40, 0.625% ZOOM carrier ampholytes 3-10,
and 1.9% ZOOM carrier ampholytes 4-7 (Invitrogen). Solubi-
lized CWP was applied on ZOOM precast immobilized pH 4-7
linear gradient strips (7.0 cm; Invitrogen) according to manu-
facturer’s instructions. Focusing was achieved using a stepwise
voltage gradient of 200, 450, 700, and 1000 V, for 10 min each
followed by focusing at 2000 V for 2 h. SDS-PAGE of the
isoelectric focusing (IEF) strips was performed using ZOOM
4-12% Bis-Tris SDS-PAGE gradient gels (Invitrogen). The gels
were stained by Coomassie blue R-250 (Bio-Rad). Images were
captured using a Gel-Doc System (Bio-Rad, Hercules, CA), and
spot detection was performed using Delta 2D software (Greif-
swald, Germany).
Two-Dimensional Liquid Chromatography. A total of 5.0
mg of TX-114 CWP was digested with modiﬁed trypsin (Roche
Diagnostics) at a ratio of 1:20 (E/S), in 0.1 M Urea and 20 mM
methylamine. The digest was desalted using Sep-Pak Light C18
cartridge (Waters, Inc.) and concentrated under vacuum. The
resultant peptides were separated by strong cation-exchange
(SCX) chromatography using a polysulfylethyl A column (460
µm × 200 mm, 300 Å; Poly LC, Inc.) connected to a Waters
Alliance analytical HPLC with a 2487 UV detector. The digest
was applied in buffer A (5 mM K2PO4, 20% acetonitrile (ACN),
pH 3.0) using a gradient of 0-80% buffer B (A with 0.5 M KCl)
over 75 min with a ﬂow rate of 1 mL/min. The elution of
peptides was monitored at 214 nm, and fractions (3 mL each)
were pooled based on UV absorbance. Each fraction (6 total)
was concentrated under vacuum and resuspended into reverse
phase buffer A (0.1% TFA in H2O). Individual SCX pools were
subjected to further separation by reversed-phase HPLC (RP-
HPLC) using a monomeric C18 column (4.6 mm × 150 mm,
Vydac). Peptides were eluted using a gradient of 0-50% reverse-
phase buffer B (90% ACN in A) over 40 min at a ﬂow rate of 1
mL/min. Peptides were manually collected based on UV
absorbance at 214 nm. A total of 139 RP-HPLC peptide fractions
were collected and concentrated under vacuum.
Mass Spectrometry. Coomassie blue stained spots were
excised from 2-DE gels and subjected to in-gel digestion
32,33
with modiﬁed trypsin (Roche Diagnostics). Digests and 2DLC
peptide fractions were resolved by liquid chromatography-mass
spectrometry (LC-MS) using either an LCQ (2DGE) or LTQ
(2DLC) as described previously.
34,50 Tandem mass spectra were
extracted, charge state deconvoluted, and deisotoped by Bio-
Works version 3.2 (Thermo Finnigan, San Jose, CA). All MS/
MS samples were analyzed using Sequest (Thermo Finnigan;
version 27, rev. 12) Sequest was set up to search the TB genome
database (version 2.0, GenBank accession no. AL123456, 3912
entries) assuming the digestion enzyme trypsin, a fragment ion
mass tolerance of 1.0 Da, a parent ion tolerance of 2.5 Da, and
3 allowable missed cleavages. Oxidation of methionine and
acrylamide adduct of cysteine (2DGE spots) were speciﬁed in
Sequest as variable modiﬁcations.
Criteria for Peptide Identiﬁcation. Peptide identiﬁcations
were accepted if they exceeded speciﬁc database search engine
thresholds. Sequest identiﬁcations required at least deltaCn
scores of greater than 0.3 and XCorr scores of greater than 1.5,
2.2, 2.5, and 2.5 for singly, doubly, triply, and quadruply charged
peptides (Supplementary Table S1).
Criteria for Protein Identiﬁcation. Scaffold (version Scaf-
fold-01_05_21, Proteome Software, Inc., Portland, OR) was used
to validate MS/MS based peptide and protein identiﬁcations.
Peptide identiﬁcations were accepted if they could be estab-
lished at greater than 90% probability as speciﬁed by the
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35 Protein identiﬁcations were ac-
cepted if they could be established at greater than 90%
probability as assigned by the Protein Prophet algorithm
35 and
contained at least two unique peptides. Protein identiﬁcations
at the lower threshold of acceptance were manually inspected
for spectra quality. The protein probability false discovery rate
for the CWP identiﬁcations was 3.5%.
36 Proteins that contained
similar peptides and could not be differentiated based on MS/
MS analysis alone were grouped to satisfy the principles of
parsimony (Supplementary Table S1).
SignalP and LipoP Interrogation. FASTA ﬁles for each
annotated Mtb protein were collected and organized into small
groups of 50. Each group was then submitted to the SignalP
server (http://www.cbs.dtu.dk/services/SignalP/)
37-39 using the
gram-positive option. The output was saved in HTML format
and a Perl script written to combine the results from all HTML
ﬁles into one ﬁle and then converted to tab delimited format.
This generated a complete list of results that were sorted in a
spreadsheet to create the subsets of Neural Network positive,
Hidden Markov Model positive, and the union of the NN and
HMM sets. These lists were input into a java application along
with the list of proteins isolated from the cell wall fractions.
This application simply compared the predicted list to those
isolated and identiﬁed the proteins found in the cell wall that
were also predicted in each subset as having a signal peptide.
To predict lipoproteins, the Mtb peptide fasta ﬁle from above
was broken down into 1000 sequences per ﬁle. These were run
through the downloadable version of LipoP (http://www.cbs-
.dtu.dk/services/LipoP/). The output ﬁles were combined in a
spreadsheet, and from the sorted data, a list was extracted with
every signal peptidase II cleavage site generating a predicted
lipoprotein list. This list was input into a Java application that
would compare the cell wall proteins, identifying the predicted
lipoproteins from each cell wall fraction. The positive results
veriﬁed that both Signal P models had predicted a signal
peptide.
Western Blot Analysis. Protein preparations from the three
CWP fractions resolved by 2DGE or SDS-PAGE were transferred
to PVDF membranes and incubated with mouse monoclonal
antibodies (R-GlcB [Rv1837c], R-PstS1 [Rv0934; IT-23], R-LprG
[Rv1411c], R-Ald [Rv2780], R-LpqH [Rv3763; IT-19]; all available
through the NIH, NIAID Contract, Tuberculosis Vaccine Testing
and Research Materials) and polyclonal antibody against
fructose bisphosphate aldolase (R-Fba [Rv0363c], kindly pro-
vided by Dr. Mary Jackson, Colorado State University) in TBS
and 0.25% Tween 80 (TBST). After incubation, membranes were
rinsed with TBST and developed using Amersham ECL Advance
Western Blotting Detection Kit (GE Healthcare Life Science,
Piscataway, NJ) as per manufacturers’ instructions. Protein
immunoblots were visualized with the Typhoon 9400 multiplex
ﬂuorescent imager (GE Healthcare Life Science, Piscataway, NJ).
Results
To maximize the resolution and protein identiﬁcation of cell
wall proteins, the delipidated cell wall of Mtb was subjected to
extraction based on solubility within three reagentssan anionic
(SDS), a chaotrophic (GuHCl), and a nonionic (TX-114) deter-
gent. 2DGE of all CWP fractions demonstrated the majority of
proteins resolving within a range of MW 25-75 kDa (Supple-
mentary Figure 1). On average, 210 spots were resolved for
GuHCl and SDS CWP fractions and 170 from TX-114. From the
2DGE analysis, 290 proteins were identiﬁed with 122, 131, and
37 proteins identiﬁed in the GuHCl, SDS, and TX-114 fractions,
respectively. For all fractions, over half were unique to each
subset (Figure 1A). Analysis of the data demonstrated 80% of
proteins had known functions (Figure 2). In contrast, the TX-
114 extracted fraction was less amenable to gel separation most
likely due to its increased hydrophobic content. A multidimen-
sional chromatography approach
40,41 was employed to better
resolve proteins in this fraction, in order to exploit any unique
or uncharacterized protein families within the TX-114 subset.
While 2DGE was insufﬁcient in identifying a signiﬁcant number
of proteins in the TX-114 detergent extract (Figure 1A), SCX
chromatography combined with reverse phase chromatography
of a digest of this CWP preparation allowed the resolution of
364 proteins, including an additional 294 proteins not found
in any of the 2DGE preparations (Figure 1B).
Validation of a few selected proteins, by Western blot analysis
of samples resolved by 2DGE (Supplementary Figure 1) and
Figure 1. (A) Identiﬁcation of cell wall proteins by two-dimen-
sional gel electrophoresis and two-dimensional liquid chroma-
tography. Detergent extraction and separation of cell wall protein
subsets via 2DGE demonstrated the majority of proteins to be
resolved using SDS and GuHCl. The lipoprotein-rich TX-114
fraction was less amenable to gel separation. See text for details.
(B) Cumulatively, separation of cell wall proteins by 2DGE
resulted in the identiﬁcation of 234 proteins. Separating the TX-
114proteinsubsetbymultidimensionalchromatography(2DLC-MS/
MS) resolved an additional 294 proteins.
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tiﬁcation of these proteins by mass spectrometry.
All identiﬁed proteins were grouped by functional category
as deﬁned by Institute Pasteur, which demonstrated Mtb
protein families present in each extract. Proteins in categories
3 (cell wall and cell wall processes) and 7 (intermediary
metabolism) were consistently overrepresented among the
CWP preparations (Figure 2). Combining the data sets of both
gel and non-gel based protein identiﬁcations led to the detec-
tion of 528 proteins (Supplementary Table S2). These were
further classiﬁed into functional groups as deﬁned by the
Sanger Institute (Figure 3A-C). One hundred and ﬁve of the
Figure 2. The functional category distribution by biological sample. Proteins identiﬁed for each extraction method (GuHCl, SDS, TX114)
were sorted by functional category as a percentage of total proteins per sample. Representation of all protein groups was identiﬁed
with the exception of groups 4 and 8 (data not shown). Seventy percent of the proteins identiﬁed in the cell wall are associated with
lipid metabolism (group 1), cell wall processes (group 3), and intermediary metabolism (group 7). In addition, 21% are conserved
hypotheticals. Black, SDS; white, GuHCl; gray, TX114; hash, total.
Figure 3. The functional category distribution of the 528 identiﬁed proteins. Assignments were made based on the Sanger Institute
gene database. The distributions are among the major functional groups and the subgroups within functional groups I and II. The
percentage for each subgroup indicates the percentage of the total number of identiﬁed proteins in its major functional group. I.X is
deﬁned by proteins involved in central intermediary metabolism, amino acid biosynthesis, polyamine synthesis, biosynthesis of cofactors,
prosthetic groups, and carriers, lipid biosynthesis, polyketide and non-ribosomal peptide synthesis, and broad regulatory functions.
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Rv no. protein name protein function
class ID
TUBERCULIST class ID SANGER
CWP
fraction
a
Rv0007 Rv0007 POSSIBLE CONSERVED MEMBRANE PROTEIN 3 V D
Rv0014c pknB TRANSMEMBRANE SERINE/THREONINE-PROTEIN KINASE B PKNB
(PROTEIN KINASE B)
9 I.J.3 D
Rv0018c pstP POSSIBLE SERINE/THREONINE PHOSPHATASE PSTP 9 I.J.3 D
Rv0092 ctpA PROBABLE CATION TRANSPORTER P-TYPE ATPASE A CTPA 3 III.A.2 B
Rv0142 Rv0142 CONSERVED HYPOTHETICAL PROTEIN 10 VI A,B
Rv0327c cyp135A1 POSSIBLE CYTOCHROME P450 135A1 CYP135A1 7 IV.F B
Rv0361 Rv0361 PROBABLE CONSERVED MEMBRANE PROTEIN 3 II.C.5 D
Rv0431 Rv0431 PUTATIVE TUBERCULIN RELATED PEPTIDE 3 II.C.2 D
Rv0497 Rv0497 PROBABLE CONSERVED TRANSMEMBRANE PROTEIN 3 II.C.5 D
Rv0512 hemB PROBABLE DELTA-AMINOLEVULINIC ACID DEHYDRATASE HEMB 7 I.G.12 C
Rv0614 Rv0614 CONSERVED HYPOTHETICAL PROTEIN 10 V A
Rv0622 Rv0622 POSSIBLE MEMBRANE PROTEIN 3 II.C.5 B
Rv0638 secE1 PROBABLE PREPROTEIN TRANSLOCASE SECE1 3 III.D D
Rv0712 Rv0712 CONSERVED HYPOTHETICAL PROTEIN 10 V B
Rv0771 Rv0771 POSSIBLE 4-CARBOXYMUCONOLACTONE DECARBOXYLASE (CMD) 7 II.B.6 D
Rv0858c Rv0858c PROBABLE AMINOTRANSFERASE 7 IV.H A
Rv0892 Rv0892 PROBABLE MONOOXYGENASE 7 I.B.7 B
Rv0899 ompA OUTER MEMBRANE PROTEIN A OMPA 3 II.C.2 D
Rv0902c prrB TWO COMPONENT SENSOR HISTIDINE KINASE PRRB 9 I.J.2 D
Rv0926c Rv0926c CONSERVED HYPOTHETICAL PROTEIN 10 V A
Rv0954 Rv0954 PROBABLE CONSERVED TRANSMEMBRANE PROTEIN 3 II.C.2 D
Rv1016c lpqT PROBABLE CONSERVED LIPOPROTEIN LPQT 3 II.C.1 D
Rv1029 kdpA PROBABLE POTASSIUM-TRANSPORTING ATPASE A CHAIN KDPA 3 III.A.2 A
Rv1096 Rv1096 POSSIBLE GLYCOSYL HYDROLASE 7 I.A.1 D
Rv1100 Rv1100 CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv1128c Rv1128c CONSERVED HYPOTHETICAL PROTEIN 5 IV.B.2 B
Rv1151c Rv1151c PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN 9 I.J.1 A
Rv1184c Rv1184c POSSIBLE EXPORTED PROTEIN 3 V D
Rv1196 PPE18 PPE FAMILY PROTEIN 6 IV.C.2 D
Rv1209 Rv1209 CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv1230c Rv1230c POSSIBLE MEMBRANE PROTEIN 3 II.C.5 B
Rv1256c cyp130 PROBA BLE CYTOCHROME P450 130 CYP130 7 IV.F B
Rv1266c pknH PROBABLE TRANSMEMBRANE SERINE/THREONINE-PROTEIN
KINASE H PKNH (STPK H)
9 I.J.3 B,D
Rv1273c Rv1273c PROBABLE DRUGS-TRANSPORT TRANSMEMBRANE ATP-BINDING
PROTEIN ABC TRANSPORTER
3 II.C.5 B
Rv1330c Rv1330c CONSERVED HYPOTHETICAL PROTEIN 10 V B
Rv1361c PPE19 PPE FAMILY PROTEIN 6 IV.C.2 A
Rv1379 pyrR PROBABLE PYRIMIDINE OPERON REGULATORY PROTEIN PYRR 9 I.J.1 D
Rv1393c Rv1393c PROBABLE MONOOXYGENASE 7 I.B.7 C
Rv1442 bisC PROBABLE BIOTIN SULFOLIDE REDUCTASE BISC (BDS reductase)
(BSO reductase)
7 I.G.1 A,D
Rv1450c PE_PGRS27 PE-PGRS FAMILY PROTEIN 6 IV.C.1.b A
Rv1451 ctaB PROBABLE CYTOCHROME C OXIDASE ASSEMBLY FACTOR CTAB 7 I.B.6.a B
Rv1466 Rv1466 CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv1586c Rv1586c PROBABLE PHIRV1 INTEGRASE 5 IV.B.3 D
Rv1594 nadA PROBABLE QUINOLINATE SYNTHETASE NADA 7 I.G.7 B
Rv1599 hisD PROBABLE HISTIDINOL DEHYDROGENASE HISD (HDH) 7 I.D.5 D
Rv1602 hisH PROBABLE AMIDOTRANSFERASE HISH 7 I.D.5 B
Rv1623c cydA PROBABLE INTEGRAL MEMBRANE CYTOCHROME D UBIQUINOL
0XIDASE (SUBUNIT I) CYDA
7 I.B.6.c D
Rv1659 argH PROBABLE ARGININOSUCCINATE LYASE ARGH 7 I.D.1 D
Rv1666c cyp139 PROBABLE CYTOCHROME P450 139 CYP139 7 IV.F A
Rv1748 Rv1748 HYPOTHETICAL PROTEIN 16 VI D
Rv1777 cyp144 PROBABLE CYTOCHROME P450 144 CYP144 7 IV.F A
Rv1801 PPE29 PPE FAMILY PROTEIN 6 IV.C.2 A
Rv1836c Rv1836c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv1957 Rv1957 HYPOTHETICAL PROTEIN 16 VI D
Rv1969 mce3D MCE-FAMILY PROTEIN MCE3D 0 IV.A A
Rv2047c Rv2047c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv2063c Rv2063c HYPOTHETICAL PROTEIN 0 VI B
Rv2095c Rv2095c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv2122c hisE PROBABLE PHOSPHORIBOSYL-AMP PYROPHOSPHATASE HISE 7 I.D.5 D
Rv2171 lppM PROBABLE CONSERVED LIPOPROTEIN LPPM 3 II.C.1 D
Rv2198c mmpS3 PROBABLE CONSERVED MEMBRANE PROTEIN MMPS3 3 II.C.4 D
Rv2205c Rv2205c CONSERVED HYPOTHETICAL PROTEIN 10 V B
Rv2211c gcvT PROBABLE AMINOMETHYLTRANSFERASE GCVT (GLYCINE
CLEAVAGE SYSTEM T PROTEIN)
7 I.C.1 D
Rv2223c Rv2223c PROBABLE EXPORTED PROTEASE 3 II.C.2 B
Rv2247 accD6 ACETYL/PROPIONYL-CoA CARBOXLASE (BETA SUBUNIT) ACCD6 1 I.H.1 A,D
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Mtb proteome publications,
16,19,22,24,27 including a compre-
hensive proteomic database http://web.mpiib-berlin.mpg.
de/cgi-bin/pdbs/2d-page/extern/index.cgi,
19 and http://web.
mpiib-berlin.mpg.de/cgi-bin/pdbs/2d-page/extern/index.cgi
42
(Table 1).
A majority of proteins were classiﬁed in either Category I,
Small Molecule Metabolism (35%), or Category II, Macromol-
ecule synthesis and degradation (25%) (Figure 3). Subclasses
of category I showed 19% classiﬁed in Small molecule metabo-
lism-other (I.X), which included the classes: Central intermedi-
ary metabolism and Amino acid biosynthesis (Figure 3; upper
right); and subclasses of category II demonstrated an even
distribution of proteins between synthesis/degradation of
macromolecules (II.A, II.B, 12.5%) and cell envelope proteins
(II.C, 12.1%) (Figure 3; lower right).
The secreted proteins of Mtb have traditionally been char-
acterized as important antigens and immune-modulators. Prior
to being exported, many of these proteins are resident within
the cell wall where their function remains largely unknown.
To ﬁnd the putative secreted proteins identiﬁed within the cell
wall proteome, all identiﬁed proteins were subject to inter-
rogation against Neural Network (NN) and Hidden Markov
model (HMM) algorithms (SignalP, http://www.cbs.dtu.dk/
services/SignalP/) which revealed 18%, 19%, 27% putative
secreted proteins in GuHCl, SDS, TX-114 CWP samples, re-
spectively, and 13% in the 2DLC resolved TX-114 CWP fraction.
Cumulatively, of the 528 proteins identiﬁed in this study, 87
Table 1. Continued
Rv no. protein name protein function
class ID
TUBERCULIST class ID SANGER
CWP
fraction
a
Rv2260 Rv2260 CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv2307c Rv2307c CONSERVED HYPOTHETICAL PROTEIN 10 V B
Rv2466c Rv2466c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv2518c lppS PROBABLE CONSERVED LIPOPROTEIN LPPS 3 II.C.1 D
Rv2556c Rv2556c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv2712c Rv2712c HYPOTHETICAL PROTEIN 16 VI A
Rv2720 leXA REPRESSOR LEXA 9 I.J.1 D
Rv2789c fadE21 PROBABLE ACYL-CoA DEHYDROGENASE FADE21 1 I.A.3 A
Rv2864c Rv2864c POSSIBLE PENICILLIN-BINDING LIPOPROTEIN 3 II.C.3 B
Rv2880c Rv2880c CONSERVED HYPOTHETICAL PROTEIN 10 V A
Rv2881c cdsA PROBABLE INTEGRAL MEMBRANE PHOSPHATIDATE
CYTIDYLYLTRANSFERASE
1 I.H.3 C
Rv2931 ppsA PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE
PPSA
1 I.I A
Rv2936 drrA PROBABLE DAUNORUBICIN-DIM-TRANSPORT ATP-BINDING
PROTEIN ABC TRANSPORTER DRRA
3 III.A.6 D
Rv2938 drrC PROBABLE DAUNORUBICIN-DIM-TRANSPORT ABC TRANSPORTER
DRRC
3 III.A.6 A,B
Rv3012c gatC PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE
(GLU-ADT SUBUNIT C)
2 II.A.3 D
Rv3083 Rv3083 PROBABLE MONOOXYGENASE (HYDROYLASE) 7 I.B.7 C
Rv3086 adhD PROBABLE ZINC-TYPE ALCOHOL DEHYDROGENASE ADHD
(ALDEHYDE REDUCTASE)
7 I.B.7 B
Rv3107c agpS POSSIBLE ALKYLDIHYDROXYACETONEPHOSPHATE SYNTHASE
AGPS (ALKYL-DHAP SYNTHASE)
1 I.B.7 B
Rv3136 PPE51 PPE FAMILY PROTEIN 6 IV.C.2 D
Rv3206c moeB1 PROBABLE MOLYBDENUM COFACTOR BIOSYNTHESIS
PROTEIN(MPT-SYNTHASE SULFURYLASE)
7 I.G.4 D
Rv3211 rhlE PROBABLE ATP-DEPENDENT RNA HELICASE RHLE 2 II.A.7 D
Rv3243c Rv3243c HYPOTHETICAL PROTEIN 16 VI A
Rv3281 Rv3281 CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv3282 Rv3282 CONSERVED HYPOTHETICAL PROTEIN 10 V A
Rv3373 echA18 PROBABLE ENOYL-CoA HYDRATASE(ENOYL HYDRASE)
(UNSATURATED ACYL-CoA HYDRATASE)
1 I.A.3 A
Rv3416 whiB3 TRANSCRIPTIONAL REGULATORY PROTEIN WHIB-LIKE WHIB3 9 I.J.1 A
Rv3421c Rv3421c CONSERVED HYPOTHETICAL PROTEIN 10 V C
Rv3448 Rv3448 PROBABLE CONSERVED INTEGRAL MEMBRANE PROTEIN 3 II.C.5 D
Rv3496c mce4D MCE-FAMILY PROTEIN MCE4D 0 IV.A C
Rv3515c fadD19 PROBABLE FATTY-ACID-CoA LIGASE FADD19 (FATTY-ACID-CoA
SYNTHETASE)
1 I.A.3 B
Rv3534c Rv3534c PROBABLE 4-HYDROXY-2-OXOVALERATE ALDOLASE (HOA) 7 II.B.6 C
Rv3565 aspB POSSIBLE ASPARTATE AMINOTRANSFERASE ASPB
(TRANSAMINASE A) (ASPAT)
7 I.D.2 B
Rv3615c Rv3615c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv3651 Rv3651 CONSERVED HYPOTHETICAL PROTEIN 10 VI D
Rv3666c dppA PROBABLE PERIPLASMIC DIPEPTIDE-BINDING LIPOPROTEIN
DPPA
3 III.A.1 C
Rv3688c Rv3688c CONSERVED HYPOTHETICAL PROTEIN 10 V D
Rv3690 Rv3690 PROBABLE CONSERVED MEMBRANE PROTEIN 3 VI D
Rv3852 Hns POSSIBLE HISTONE-LIKE PROTEIN HNS 2 II.A.4 D
Rv3877 Rv3877 PROBABLE CONSERVED TRANSMEMBRANE PROTEIN 3 V B
Rv3903c Rv3903c HYPOTHETICAL ALANINE AND PROLINE RICH PROTEIN 16 VI B
a Cell Wall Protein fractions: A, 2% SDS; B, 6M GuHCl; C, 4% TX-114; D, 2DLC TX-114.
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a
CWP fractions secreted
Rv no. protein name GuHCl SDS TX-114 2DLC experimental
b predicted
c NetOglyc motif reference
Rv0125 pepA x yes yes 42, 16
Rv0129c fbpC x x x yes yes 42, 19, 16
Rv0169 mce1A x 24
Rv0172 mce1D x yes 16
Rv0173 lprK x yes 16
Rv0174 mce1F x 16, 19
Rv0194 Rv0194 x 24
Rv0202c mmpL11 x x x 24
Rv0227c Rv0227c x 24, 46
Rv0237 lpqI x yes yes 16, 46
Rv0291 mycP3 x yes 16
Rv0292 Rv0292 x 46
Rv0309 Rv0309 x yes 16
Rv0338c Rv0338c x 24, 46
Rv0402c mmpL1 x yes 16
Rv0431 Rv0431 x
Rv0432 sodC x x yes 45, 46, 19
Rv0480c Rv0480c x 24
Rv0507 mmpL2 x 24
Rv0512 hemB x
Rv0559c Rv0559c x yes 42, 16
Rv0583c lpqN x yes yes 16, 19
Rv0622 Rv0622 x
Rv0830 Rv0830 x 46
Rv0858c Rv0858c x
Rv0892 Rv0892 x
Rv0902c prrB x
Rv0928 pstS3 x yes yes 16, 45
Rv0934 pstS1 x x x yes yes yes 42, 19, 16, 46
Rv1006 Rv1006 x x 24, 46
Rv1016c lpqT x yes 46
Rv1029 kdpA x
Rv1075c Rv1075c x yes 16, 19
Rv1096 Rv1096 x
Rv1130 Rv1130 x 24
Rv1184c Rv1184c x
Rv1209 Rv1209 x
Rv1230c Rv1230c x
Rv1244 lpqZ x 46, 19
Rv1269c Rv1269c x yes 42, 16
Rv1270c lprA x x yes yes 16, 46, 19
Rv1273c Rv1273c x
Rv1275 lprC x 24, 46
Rv1307 atpH x 24, 46
Rv1368 lprF x x yes 46, 24, 22
Rv1411c lprG x x yes 46, 24, 22
Rv1450c PE_PGRS27 x
Rv1488 Rv1488 x yes 16, 24, 22
Rv1522c mmpL12 x 22
Rv1815 Rv1815 x yes 16
Rv1886c fbpB x x yes yes 42, 16, 22
Rv1911c lppC x yes yes 22, 46
Rv1926c mpt63 x yes yes 42, 16
Rv1969 mce3D x
Rv1980c mpt64 x yes yes 42, 16
Rv1984c cfp21 x yes 16
Rv2095c Rv2095c x
Rv2171 lppM x
Rv2216 Rv2216 x 22
Rv2223c Rv2223c x
Rv2307c Rv2307c x
Rv2345 Rv2345 x 46, 22
Rv2376c cfp2 x yes yes 19, 16
Rv2518c lppS x
Rv2531c Rv2531c x 24
Rv2536 Rv2536 x 24
Rv2576c Rv2576c x 16
Rv2625c Rv2625c x 22
Rv2631 Rv2631 x 16
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included the identiﬁcation of 23 proteins uniquely found in
this study (Table 2). A majority (60%) of the CWP associated
with secretion are indeed within the category of the cell wall
and its processes (Figure 4). Further, many of these CWP are
also membrane associated, either by description
22,24,25 or
functional annotation. Of the 23 secreted CWP unique to this
study, 11 have been described to be involved with small
molecule and peptide binding. Additionally, 23 of the 87
secreted proteins are classiﬁed as hypothetical or unknown
(Categories V and VI of Sanger Institute) illustrating that to a
large extent, the functions of these exported proteins are poorly
understood.
Next, we interrogated the CWP to identify those with putative
lipoprotein motifs. Here, a total of 16 proteins were predicted
by LipoP (LipoP, http://www.cbs.dtu.dk/services/LipoP/)
43 to
contain a signal peptidase II cleavage motif, and an additional
8 proteins were identiﬁed when compared to the 99 putative
lipoproteins (2.5% of the genome) that reportedly exist within
the Mtb proteome.
7 A majority of the lipoproteins contain no
additional functional classiﬁcation; however, 4 proteins (Rv0928,
Rv0934, Rv2864c, Rv3666c) are involved with substrate binding
and transport within the periplasm. One of two superoxide
dismutases in Mtb, SodC (Rv0432), was also identiﬁed within
the lipoprotein-enriched TX-114 CWP fraction. This protein has
recently been deﬁned as a highly glycosylated putative lipo-
protein and is a deﬁned B-cell antigen.
44,45 Other putative
lipoproteins identiﬁed in this study contain O-glycosylation
motifs as predicted by NetOglyc and were found within the
Mtb glycoproteome (Table 2).
46 The function of these dual-
modiﬁed lipo-glycoproteins, as well as the nature of their
modiﬁcation remain largely undeﬁned.
Discussion
In this study, we focused on the gel-based two-dimen-
sional separation of the cell wall and complemented that
separation by liquid chromatography of digested TX-114
CWP. Identiﬁed protein families included known antigens,
Fbp A, B, and C (Rv 3804c, Rv1886c, and Rv0129c), CFP10
(Rv3874) and Esat-6 like proteins EsxJ and EsxL (Rv1038c,
Rv1198) along with antigens lpqH (Rv3763), lprG (Rv1411c),
and lprA (Rv1270c). Others included members of the MmpL
and Mce protein family of lipid export machinery. In
concordance with previous work,
26,47 a number of ribosomal
proteins are reported here, which must indicate a high level
of protein synthesis occurring at the cytosol-cell wall
interface, most likely to facilitate the entry of proteins into
the cellular envelope.
For over a decade, the advancement of techniques in
2DGE, mass spectrometry, and increased access to bioin-
formatic tools greatly enhanced proteomic studies of Mtb.
Largely descriptive, these studies were undertaken to identify
novel virulence factors and drug targets.
18,19,27 Subsequent
studies set out to understand functional relationships be-
tween proteins and discover antigens responsible for adap-
tive T-cell responses.
23,24,26,48,49 The quantitative techniques
Table 2. Continued
CWP fractions secreted
Rv no. protein name GuHCl SDS TX-114 2DLC experimental
b predicted
c NetOglyc motif reference
Rv2712c Rv2712c x
Rv2721c Rv2721c x x 16
Rv2756c hsdM x 24
Rv2864c Rv2864c x
Rv2945c lppX x x yes 16, 46, 24, 22
Rv3006 lppZ x yes 16, 46, 22
Rv3106 fprA x 22
Rv3193c Rv3193c x 16, 22
Rv3224 Rv3224 x x yes 42, 19, 24, 22
Rv3243c Rv3243c x
Rv3244c lpqB x yes 16, 46
Rv3584 lpqE x 16, 22
Rv3623 lpqG x yes 24, 22
Rv3666c dppA x
Rv3682 ponA2 x 16, 24, 22
Rv3725 Rv3725 x 16
Rv3763 lpqH x x yes yes 19, 46, 24, 22
Rv3804c fbpA x x yes yes 42, 19, 16, 24, 22
a Proteins in bold indicate putative lipoprotein.
b Experimental evidence reported for secretion. See reference.
c Predicted Signal Petptidase I cleavage
(SignalP, http://www.cbs.dtu.dk/services/SignalP/).
Figure 4. Functional classiﬁcation for putative secreted proteins
and lipoproteins. Eighty-seven cell wall proteins were predicted
to contain secretion signals and putative lipoprotein motifs. Sixty
percent of these proteins are classiﬁed within the cell wall and
cell wall processes functional category.
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(iCAT) and isobaric tagging for relative and absolute quan-
tiﬁcation (iTRAQ), have afforded the accurate monitoring of
up- and down-regulation of proteins on a global scale.
23,50
Previous work mining subcellular fractions of Mtb, focused
on the cytosol and culture ﬁltrate fractions, resulted in
thorough characterization and the creation of 2D gel
databases.
19,42,51-53 Efforts have been made more recently
to resolve the insoluble cell wall fraction. As mentioned
previously, Mawuenyega et al. was able to identify 300
proteins within the cell wall using 2DLC as a separation
method. Their study demonstrated functional relationships
among key protein families within the fatty-acid synthesis
pathway. Using these studies as experimental platforms, we
were able to focus on the Mtb cell wall and were successful
in reporting over 100 additional proteins that had not been
identiﬁed previously. The elucidation of the cell wall pro-
teome can facilitate subsequent studies of a more targeted
nature where speciﬁc proteins can be monitored in response
to various environmental, nutritional, or drug pressures.
One of the most interesting yet poorly understood protein
families residing within the cell wall of Mtb are the triacylated
lipoproteins. As stated above, Sutcliffe et al. predicted 2.5%
of the genome to encode for lipoproteins. Deﬁning these
proteins beyond their antigenic and immune modulatory
potential remains quite elusive with only a few studies
predicting functional roles for Mtb lipoproteins.
13,54-56 In
this study, a vast majority of proteins found were involved
in small molecule and macromolecule metabolism. Specif-
ically, many of the CWP were annotated as small molecule
and nutrient binding. This builds upon the evidence that
clearly deﬁnes two Mtb CW lipoproteins, LppX and LprG, as
aiding and/or facilitating the transport of lipids
57 and small
molecules,
58 respectively. The presence of these lipoproteins
and perhaps other secreted, CW resident proteins provides
a conduit between various nutrient transportation pathways
that are required for cellular survival and growth while
allowing the mycobacterial cell wall to maintain its rigid
hydrophobic integrity. While bacterial cell walls have histori-
cally been thought of as structural scaffolding with little
active interplay between the extracellular milieu and inner
cytosolic environment, this perception of a static bacterial
structure is fading and we are beginning to understand the
true complexity and dynamic nature of the biological
processes being facilitated within the cell wall. For instance,
these proteins may contribute to bacterial cell wall remodel-
ing events in response to environmental stressors such as
nutrient depletion, antibiotic pressures, the host immune
response, and tissue remodeling events throughout the
course of infection. For Mtb, the highly complex framework
of the mAGP-outer lipid architecture can now be deﬁnitively
complemented with a highly diverse protein population. This
new perspective will provide further insight into cell wall
remodeling processes during mycobacterial infection as well
as give a more comprehensive list of potential drug targets
and diagnostic candidates.
Conclusion
The cell wall proteins of Mtb were extracted and resolved
by 2DGE or 2DLC. Several classes of proteins were identiﬁed,
including putative secreted proteins, lipoproteins, and known
T and B cell antigens. Many proteins have unknown function;
however, their presence within the cell wall may be of biological
relevance.
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